在Clostridioides difficile感染后,刺激性肠综合征
Teodora Iacob1, Giuseppe Guido Maria Scarlata2, Ludovico Abenavoli2
1Hospital for Infectious Diseases, Cluj-Napoca, Romania.
Medicine and pharmacy reports
|August 11, 2025
概括
感染后刺激性肠综合征 (PI-IBS) 在克洛斯特里迪奥伊德困难感染 (CDI) 后超过一半的患者中发生. 严重的CDI病例显示PI-IBS的风险更高,需要主动管理以防止长期的胃肠道问题.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 刺激性肠综合征 (IBS) 是一种慢性功能性胃肠疾病.
- 后感染性IBS (PI-IBS) 可以在急性胃肠炎后发展,包括Clostridioides difficile感染 (CDI).
- 有限的数据存在于CDI后PI-IBS的风险和严重程度的相关性.
研究的目的:
- 评估在确诊的CDI后发展PI-IBS的风险.
- 调查CDI严重程度与PI-IBS发作之间的相关性.
主要方法:
- 一项涉及38名确诊CDI患者和31名对照者的横截面研究.
- 通过住院,实验室参数和症状评估CDI的严重程度.
- 在CDI后六个月使用罗马IV标准和布里斯托尔便尺度诊断PI-IBS.
主要成果:
- PI-IBS发生在57%的CDI组中,而对照组中只有25% (RR=2.29,p=0.04).
- 在CDI严重程度和PI-IBS风险之间发现了显著的相关性.
- 90%的住院CDI患者患有PI-IBS (RR=2.72,p=0.0493).这些患者中,有90%的患者患有PI-IBS (RR=2.72,p=0.0493).
结论:
- 超过一半的患者在CDI后六个月经历了PI-IBS.
- 增加的CDI严重程度与PI-IBS的更高风险相关.
- 积极管理严重的CDI对于预防长期的胃肠道并发症至关重要.
更多相关视频
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.2K
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
12.7K
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
382
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
382
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245
01:17Drugs for Treatment of Diarrhea-Predominant IBS
294
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
294
01:30Inflammatory Bowel Disease II: Crohn's Disease
383
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
01:17Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
01:21Drugs for Treatment of Constipation-Predominant IBS
333
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
333